282. 先天性赤血球形成異常性貧血 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 3) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 10

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Analysis OF genetic modifiers
   Hospital Universitari Vall d'Hebron Research Institute
      2020   -   NCT07206095   Spain
Disease phenotyping
   Hospital Universitari Vall d'Hebron Research Institute
      2020   -   NCT07206095   Spain
Luspatercept
   FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
      2023   Phase 2   EUCTR2020-005736-30-IT   Italy
Omeprazole
   Soroka University Medical Center
      2013   Phase 4   NCT01795794   -
Reblozyl
   FOndazione per la Ricerca sulle ANemie ed EMoglobinopatie in ItaliA - For Anemia
      2023   Phase 2   EUCTR2020-005736-30-IT   Italy
Zoledronic acid
   Institute of Hematology & Blood Diseases Hospital, China
      2026   Phase 1/Phase 2   NCT07471516   China